Literature DB >> 20061558

Identification of DJ-1/PARK-7 as a determinant of stroma-dependent and TNF-alpha-induced apoptosis in MDS using mass spectrometry and phosphopeptide analysis.

A Mario Marcondes1, Xiang Li, Ted A Gooley, Brian Milless, H Joachim Deeg.   

Abstract

In patients with myelodysplastic syndromes (MDS), apoptosis in hematopoietic cells is up-regulated in low-grade disease, whereas advanced disease is characterized by apoptosis resistance. We have shown that marrow stroma-derived signals convey sensitivity to tumor-necrosis-factor alpha (TNF-alpha)-mediated apoptosis in otherwise-resistant KG1a myeloid cells and CD34(+) cells from MDS marrow. Here, we used a PhosphoScan proteomic liquid chromatography-mass spectrometry method to identify signals relevant for this effect. The transcription factor DJ-1/PARK-7 (DJ-1) was highly phosphorylated in KG1a cells cultured without stroma but dephosphorylated after stroma coculture, whereas expression of p53 increased significantly, suggesting a stroma contact-dependent effect of DJ-1 on p53. In CD34(+) marrow cells from advanced MDS, expression of DJ-1 was up-regulated, whereas p53 levels were low, resulting in significantly greater DJ-1/p53 ratios than in patients with low-grade MDS (P = .01). DJ-1 levels were correlated with increasing International Prognostic Scoring System scores (P = .006). Increasing DJ-1/p53 ratios were associated with an increased risk of mortality, although the correlation did not reach statistical significance (P = .18). These data suggest that DJ-1/p53 interactions contribute to apoptosis resistance in clonal myeloid cells and may serve as a prognostic marker in patients with MDS.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20061558      PMCID: PMC2837333          DOI: 10.1182/blood-2009-08-236992

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  37 in total

1.  Characterization and functional analysis of laminin isoforms in human bone marrow.

Authors:  U Siler; M Seiffert; S Puch; A Richards; B Torok-Storb; C A Müller; L Sorokin; G Klein
Journal:  Blood       Date:  2000-12-15       Impact factor: 22.113

2.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

3.  Expansion and transduction of nonenriched human cord blood cells using HS-5 conditioned medium and FLT3-L.

Authors:  M Goerner; B Roecklein; B Torok-Storb; S Heimfeld; H P Kiem
Journal:  J Hematother Stem Cell Res       Date:  2000-10

4.  Deacetylation of p53 modulates its effect on cell growth and apoptosis.

Authors:  J Luo; F Su; D Chen; A Shiloh; W Gu
Journal:  Nature       Date:  2000-11-16       Impact factor: 49.962

5.  Immunohistochemical detection of p53, mdm2, waf1/p21, and Ki67 proteins in bone marrow biopsies in myelodysplastic syndroms, acute myelogenous leukaemias and chronic myeloproliferative disorders.

Authors:  P Kanavaros; K Stefanaki; D Rontogianni; K Darivianaki; M Vlychou; E Papadaki; G Eliopoulos; M Bakiri; C Matsouka; S Kakolyris; V Georgoulias
Journal:  Clin Exp Pathol       Date:  1999

6.  Comparison of gene expression in CD34+ cells from bone marrow and G-CSF-mobilized peripheral blood by high-density oligonucleotide array analysis.

Authors:  L Graf; S Heimfeld; B Torok-Storb
Journal:  Biol Blood Marrow Transplant       Date:  2001       Impact factor: 5.742

7.  Twist and p53 reciprocally regulate target genes via direct interaction.

Authors:  M Shiota; H Izumi; T Onitsuka; N Miyamoto; E Kashiwagi; A Kidani; G Hirano; M Takahashi; S Naito; K Kohno
Journal:  Oncogene       Date:  2008-05-26       Impact factor: 9.867

8.  Therapeutic targeting of the MEK/MAPK signal transduction module in acute myeloid leukemia.

Authors:  M Milella; S M Kornblau; Z Estrov; B Z Carter; H Lapillonne; D Harris; M Konopleva; S Zhao; E Estey; M Andreeff
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

9.  Negative regulators of hemopoiesis and stroma function in patients with myelodysplastic syndrome.

Authors:  H J Deeg; C Beckham; M R Loken; E Bryant; M Lesnikova; H M Shulman; T Gooley
Journal:  Leuk Lymphoma       Date:  2000-04

10.  Stromal cells prevent apoptosis of AML cells by up-regulation of anti-apoptotic proteins.

Authors:  M Konopleva; S Konoplev; W Hu; A Y Zaritskey; B V Afanasiev; M Andreeff
Journal:  Leukemia       Date:  2002-09       Impact factor: 11.528

View more
  7 in total

1.  Deficiency in the anti-apoptotic protein DJ-1 promotes intestinal epithelial cell apoptosis and aggravates inflammatory bowel disease via p53.

Authors:  Jie Zhang; Min Xu; Weihua Zhou; Dejian Li; Hong Zhang; Yi Chen; Longgui Ning; Yuwei Zhang; Sha Li; Mengli Yu; Yishu Chen; Hang Zeng; Li Cen; Tianyu Zhou; Xinxin Zhou; Chao Lu; Chaohui Yu; Youming Li; Jing Sun; Xiaoni Kong; Zhe Shen
Journal:  J Biol Chem       Date:  2020-02-18       Impact factor: 5.157

2.  The helix-loop-helix transcription factor TWIST is dysregulated in myelodysplastic syndromes.

Authors:  Xiang Li; A Mario Marcondes; Theodore A Gooley; H Joachim Deeg
Journal:  Blood       Date:  2010-06-18       Impact factor: 22.113

3.  Expression parameters of the metabolic pathway genes pyruvate dehydrogenase kinase-1 (PDK-1) and DJ-1/PARK7 in renal cell carcinoma (RCC).

Authors:  Daniel Baumunk; Uta Reichelt; Jannis Hildebrandt; Hans Krause; Jan Ebbing; Hannes Cash; Kurt Miller; Martin Schostak; Steffen Weikert
Journal:  World J Urol       Date:  2012-04-29       Impact factor: 4.226

4.  Transcriptional regulation of miR-10a/b by TWIST-1 in myelodysplastic syndromes.

Authors:  Xiang Li; Feng Xu; ChunKang Chang; John Byon; Thalia Papayannopoulou; H Joachim Deeg; A Mario Marcondes
Journal:  Haematologica       Date:  2012-09-14       Impact factor: 9.941

5.  Effect of intravenous coadministration of human stroma cell lines on engraftment of long-term repopulating clonal myelodysplastic syndrome cells in immunodeficient mice.

Authors:  X Li; A M Marcondes; T Ragoczy; A Telling; H J Deeg
Journal:  Blood Cancer J       Date:  2013-04-26       Impact factor: 11.037

6.  Screening differentially expressed proteins from co-cultured hematopoietic cells and bone marrow-derived stromal cells by quantitative proteomics (SILAC) method.

Authors:  Rui Liu; Yi Wang; Bingxin Li; Hui Wang; Feng Guan; Zengqi Tan; Xiang Li
Journal:  Clin Proteomics       Date:  2019-07-18       Impact factor: 3.988

7.  The KDM2B- let-7b -EZH2 axis in myelodysplastic syndromes as a target for combined epigenetic therapy.

Authors:  Ekapun Karoopongse; Cecilia Yeung; John Byon; Aravind Ramakrishnan; Zaneta J Holman; Peter Y Z Jiang; Qiang Yu; H Joachim Deeg; A Mario Marcondes
Journal:  PLoS One       Date:  2014-09-16       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.